COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Yowie Announces Allergen Packaging Update
Yowie will make packaging changes to transparently disclose potential cross-contamination of peanuts and tree nuts in the manufacturing facility while emphasizing their nut-free recipe. Join the wildlife conservation adventure with Yowie bigfoot characters and surprise-inside chocolates -
-
COMMUNIQUÉ RÉGLEMENTÉ
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE AU 31.01.24
Déclaration relative au nombre de droits de vote et d'actions composant le capital de la société Manitou BF conformément à l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers -
-
COMMUNIQUÉ DE PRESSE
Margulies Perruzzi Expands Healthcare Studio with New Hire, Promotions
Margulies Perruzzi (MP) expands its healthcare studio with the addition of Milly Baker as Senior Medical Planner and the promotions of John Fowler to Director of Healthcare and Julia Donahue to Job Captain. MP's healthcare services include programming, planning, sustainable design, and LEAN process improvement -
COMMUNIQUÉ DE PRESSE
PRODIGY BIOTECH CONCLUT UN ACCORD DE PARTENARIAT AVEC UN CENTRE DE CANCÉROLOGIE LEADER
Prodigy Biotech conclut un accord de partenariat avec un centre de cancérologie leader pour améliorer les résultats de greffe de cellules souches hématopoïétique allogénique. MSK et Prodigy développeront un produit ciblant Enterococcus sp. pour traiter la dysbiose microbienne -
COMMUNIQUÉ DE PRESSE
PRODIGY BIOTECH ENTERS INTO A PARTNERSHIP AGREEMENT WITH LEADING CANCER CENTER TO ADVANCE PRODUCTS TO IMPROVE OUTCOMES IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Prodigy Biotech partners with leading cancer center MSK to develop products improving outcomes in patients undergoing allogenic hematopoietic stem cell transplantation. The collaboration aims to evaluate a product targeting Enterococcus sp. to treat microbial dysbiosis and reset the gut microbiome, potentially mitigating disease severity -
COMMUNIQUÉ DE PRESSE
Pathify Shatters Expectations for Fourth Straight Year
Pathify achieves 65% annual revenue growth for fiscal year 2023, surpasses 1,000,000 unique lifetime users, and expands partnerships with higher education organizations. Plans to introduce GenAI-powered chatbot and major additions to the Communities module in 2024
